Amogen Pharma
Hyderabad, India amogenpharma.com From their website, Nov 2026
- GLP
- GMP
Work here? Claim this listing
About
Amogen Pharma develops and manufactures recombinant peptide and protein biosimilars for pharmaceutical partners. It operates from Hyderabad, India, with an office in Basel, Switzerland, and serves programs from early development through commercial supply.
Amogen Pharma is a CRDMO in Hyderabad, India, founded in 2020. It lists 12 services, including Microbial development services, Process development and Non-GMP/CGMP manufacturing. It names GLP and GMP on its listing.
Services
Microbial development services
Genetic engineering, strain development, and microbial development in E. coli and yeast.
Process development
Upstream and downstream process development from bench to commercial scale.
Non-GMP/CGMP manufacturing
Flexible manufacturing from non-GMP toxicology through cGMP clinical and commercial supply.
CDMO: development & manufacturing
Microbial manufacturing services
Production of recombinant proteins and peptides with clinical and commercial supply capabilities.
CDMO: development & manufacturing
Analytical development
Comprehensive analytical method development, qualification, and transfer.
Microbial analytical services
Bioassays, ELISA, microbiology, molecular biology, and related testing support.
Strain development
Development of high-expressing, stable cell lines and strains.
Cell line development
Proprietary platform processes for generating high-expressing, stable cell lines.
4 more services
- Quality services
- API supply
- FDF licensing
- Co-development
- Lead time
- NDA signed within 48 hours
- What to send
- Molecule information
- Target markets
- Development stage
- Volume requirements
- Analytical package review under NDA
- Minimums and prices
- Volume-linked pricing
How to order from Amogen Pharma
What to send, as they list it: Molecule information; Target markets; Development stage; Volume requirements; Analytical package review under NDA. Minimums and prices they state: Volume-linked pricing. Lead time they state: NDA signed within 48 hours. They take requests through the contact form on their website. You can contact them directly from this page, or request a quote through Midgard.
Capabilities
As they state on their website or in their listing.
- Processes
- Small molecule
- Peptide
- Recombinant protein
- Biosimilar
- E. coli expression
- HPLC
6 more
- Bioreactors
- Process development
- Analytical development
- qPCR
- ELISA
- Toxicology
- Capacity
- 75,000 L total fermentation capacity
- 100L pre-seed bioreactor x2
- 1000L seed bioreactor x4
- 10,000L production bioreactor x5
- 4 x 10,000L trains
- 15,000L production scale
3 more
- 980 kg semaglutide API capacity annually
- 980 kg GLP-1 fermentation output plant
- 5 x 15KL production fermenters
- Scales
- Kilogram
- Data supplied
- LC-MS · HPLC
Equipment
- UHPLC
- HPLC-UV/PDA
- LC-MS
- HRMS
- SEC-HPLC
- qPCR
- Preparative Chromatography
Certifications
As the company states them, with the certificate or registry record where there is one.
GLPSelf-reported
GMPSelf-reported
Scope: microbial production facility
Company
- Type
- CRDMO
- Founded
- 2020
- Team
- 75+ Scientific & Manufacturing Experts
Locations
- Based in
- Hyderabad, India
- Sites
- Basel, Switzerland
- Serves
- Global, India, UAE, Saudi Arabia, Qatar, Kuwait, Bahrain, Oman, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Canada
Public records
- Parent company
- AMOGEN PHARMA PRIVATE LIMITED · IN GLEIF